The Impact of the 2007 ATS/IDSA Diagnostic Criteria for Nontuberculous Mycobacterial Disease on the Diagnosis of Nontuberculous Mycobacterial Lung Disease

Background: In 2007, the American Thoracic Society (ATS) and Infectious Disease Society of America (IDSA) published new diagnostic guidelines for nontuberculous mycobacterial (NTM) disease. Bacteriological criteria have become simpler compared to the 1997 ATS diagnostic criteria. Objective: For assessing the impact of the 2007 ATS/IDSA diagnostic criteria, we compared the diagnosis rate and time to diagnosis of NTM lung disease using the 1997 and 2007 ATS guidelines. Methods: Sixty-four patients who had excreted Mycobacterium intracellulare, M. avium, M. abscessus or M. kansasii at least one time in their respiratory specimens at Chonnam National University Hospital were reviewed. The 1997 ATS and 2007 ATS/IDSA guidelines were applied to these patients. Results: Thirty-seven of 64 patients (57.8%) were diagnosed with NTM lung disease by the 1997 ATS criteria. When the 2007 ATS/IDSA criteria were applied, 6 patients were newly diagnosed with NTM lung disease. The diagnosis rate significantly increased from 57.8 to 67.2% (p < 0.001). The time to diagnosis in the 1997 ATS and 2007 ATS/IDSA guidelines was 46.4 ± 53.0 and 36.2 ± 38.5 days, respectively (p = 0.002). Conclusion: These data suggest that we can shorten the time to diagnose NTM lung disease and diagnose more simply by using the 2007 ATS/IDSA guidelines. Further study will be needed to assess that these changes affect the management of NTM disease.

[1]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[2]  S. Ichiyama,et al.  The Isolation of Mycobacterium avium Complex from Soil, Water, and Dusts , 1988, Microbiology and immunology.

[3]  F. Drobniewski Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999 , 2000, Thorax.

[4]  D. van Soolingen,et al.  Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands , 2009, Thorax.

[5]  M. Iseman Mycobacterium avium Complex and the Normal Hosts , 1989 .

[6]  M. Patarroyo,et al.  Multiprimer PCR system for differential identification of mycobacteria in clinical samples , 1996, Journal of clinical microbiology.

[7]  D. van Soolingen,et al.  Impact of new American Thoracic Society diagnostic criteria on management of nontuberculous mycobacterial infection. , 2007, American journal of respiratory and critical care medicine.

[8]  Y. Fujita,et al.  Analysis of Chest CT in Patients with Mycobacterium avium Complex Pulmonary Disease , 2003, Respiration.

[9]  K. Lee,et al.  Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases: A Korean Perspective , 2005, Journal of Korean medical science.

[10]  R. Wallace,,et al.  Diagnosis and treatment of disease caused by nontuberculous mycobacteria. , 1990, The American review of respiratory disease.

[11]  T. Marras,et al.  Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007. , 2011, Canadian respiratory journal.

[12]  T. Marras,et al.  Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003 , 2007, Thorax.

[13]  E. Patz,et al.  Pulmonary nontuberculous mycobacterial infection: radiologic manifestations. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[14]  C. Daley,et al.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria. , 2002, Clinics in chest medicine.

[15]  M. Iseman Mycobacterium avium complex and the normal host: the other side of the coin. , 1989, The New England journal of medicine.

[16]  P. Pickkers,et al.  Renal effects of nitric oxide during sepsis: another two-edged sword? , 2007, American journal of respiratory and critical care medicine.

[17]  D. Peterson,et al.  Infection with Mycobacterium avium complex in patients without predisposing conditions. , 1989, The New England journal of medicine.

[18]  M. Morgan,et al.  Multicenter Evaluation of the BACTEC MGIT 960 System for Recovery of Mycobacteria , 1999, Journal of Clinical Microbiology.

[19]  Yoshihiro Kobashi,et al.  The Microbiological and Clinical Effects of Combined Therapy according to Guidelines on the Treatment of Pulmonary Mycobacterium avium Complex Disease in Japan – Including a Follow-Up Study , 2006, Respiration.

[20]  P. Kao,et al.  Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. , 1999, Chest.

[21]  T. B. Taylor,et al.  Routine use of PCR-restriction fragment length polymorphism analysis for identification of mycobacteria growing in liquid media , 1997, Journal of clinical microbiology.